Institutionelle bei Human Genome

Im Folgenden steht an erster Stelle der Name des institutionellen Shareholders bzw. Fonds, an zweiter Stelle die Anzahl der gehaltenen Aktien und an dritter Stelle der Wert des gehaltenen Aktienpakets.

Institutionelle Shareholder
JP Morgan Chase & Company 9,336,582 $124,083,174
AXA Financial, Inc. 6,293,692 $83,643,166
Morgan Stanley 4,579,683 $60,863,987
FMR Corporation (Fidelity Management & Research Corp) 17,174,820 $228,253,357
Panther City Investment Company 2,395,780 $31,839,916
TCW Group, Inc. (The) 2,368,094 $31,471,969
Bass, (Lee, M), Inc. 2,144,024 $28,494,078
Dresdner Rcm Global Investors LLC 2,114,168 $28,097,292
Barclays Bank Plc 2,100,548 $27,916,282
Taunus Corporation 2,096,731 $27,865,554

Topliste der investierten Fonds
Fidelity Growth Company Fund 5,541,410 $73,645,338
Fidelity Aggressive Growth Fund 3,499,500 $46,508,355
Fidelity Select Portfolios - Biotechnology 2,693,600 $35,797,944
Homestead Funds Inc-Nasdaq 100 Index Tracking Stock Fund 2,461,482 $32,713,095
Janus Aspen Aggressive Growth Portfolio 1,738,773 $23,108,293
American Aadvantage Large Cap Growth Fund 1,600,000 $21,264,000
Janus Worldwide Fund 1,368,480 $18,187,099
Oppenheimer Global Fund 1,328,800 $17,659,752
Variable Insurance Products Fd-Growth Portfolio 1,208,400 $16,059,636
College Retirement Equities Fund-Stock Account 1,133,920 $15,069,796